Future therapies for hepatitis C
β Scribed by Asim S. Khokhar; Valerie Byrnes; Nezam H. Afdhal
- Book ID
- 107540437
- Publisher
- Current Science Inc.
- Year
- 2006
- Tongue
- English
- Weight
- 211 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Currently available therapies for the treatment of chronic hepatitis C are effective in half of patients, but are expensive, often poorly tolerated, and unsuitable for certain patient populations. The ideal therapy would be highly effective, orally bioavailable, have minimal side effects, be cost ef
See Articles on Pages 631 and 640. N o challenge in clinical hepatology is as great today as the management of patients with chronic hepatitis C who have failed to respond to an adequate course of antiviral therapy. At present, the optimal regimen is a combination of peginterferon and ribavirin. 1 W